262 related articles for article (PubMed ID: 31511615)
1. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
[TBL] [Abstract][Full Text] [Related]
2. Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.
Le Rouzic E; Morel M; Ayinde D; Belaïdouni N; Letienne J; Transy C; Margottin-Goguet F
J Biol Chem; 2008 Aug; 283(31):21686-92. PubMed ID: 18524771
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.
Romani B; Baygloo NS; Hamidi-Fard M; Aghasadeghi MR; Allahbakhshi E
J Biol Chem; 2016 Feb; 291(6):2696-711. PubMed ID: 26679995
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
Romani B; Kamali Jamil R; Hamidi-Fard M; Rahimi P; Momen SB; Aghasadeghi MR; Allahbakhshi E
Sci Rep; 2016 Aug; 6():31924. PubMed ID: 27550312
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.
Ahn J; Vu T; Novince Z; Guerrero-Santoro J; Rapic-Otrin V; Gronenborn AM
J Biol Chem; 2010 Nov; 285(48):37333-41. PubMed ID: 20870715
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP.
Maudet C; Sourisce A; Dragin L; Lahouassa H; Rain JC; Bouaziz S; Ramirez BC; Margottin-Goguet F
PLoS One; 2013; 8(10):e77320. PubMed ID: 24116224
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.
Zhang F; Bieniasz PD
Elife; 2020 Jun; 9():. PubMed ID: 32538781
[TBL] [Abstract][Full Text] [Related]
9. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.
Marban C; Suzanne S; Dequiedt F; de Walque S; Redel L; Van Lint C; Aunis D; Rohr O
EMBO J; 2007 Jan; 26(2):412-23. PubMed ID: 17245431
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpr Reprograms CLR4
Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
[TBL] [Abstract][Full Text] [Related]
11. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpr hijacks EDD-DYRK2-DDB1
Hossain D; Ferreira Barbosa JA; Cohen ÉA; Tsang WY
J Biol Chem; 2018 Jun; 293(24):9448-9460. PubMed ID: 29724823
[TBL] [Abstract][Full Text] [Related]
13. Vpr Targets TET2 for Degradation by CRL4
Lv L; Wang Q; Xu Y; Tsao LC; Nakagawa T; Guo H; Su L; Xiong Y
Mol Cell; 2018 Jun; 70(5):961-970.e5. PubMed ID: 29883611
[TBL] [Abstract][Full Text] [Related]
14. Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
Barbosa JAF; Sparapani S; Boulais J; Lodge R; Cohen ÉA
J Virol; 2021 Jul; 95(15):e0097120. PubMed ID: 34011540
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
[TBL] [Abstract][Full Text] [Related]
16. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.
Casey Klockow L; Sharifi HJ; Wen X; Flagg M; Furuya AK; Nekorchuk M; de Noronha CM
Virology; 2013 Sep; 444(1-2):191-202. PubMed ID: 23849790
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.
Lapek JD; Lewinski MK; Wozniak JM; Guatelli J; Gonzalez DJ
Mol Cell Proteomics; 2017 Aug; 16(8):1447-1461. PubMed ID: 28606917
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Vpr redirects host ubiquitination pathway.
Arora S; Verma S; Banerjea AC
J Virol; 2014 Aug; 88(16):9141-52. PubMed ID: 24899191
[TBL] [Abstract][Full Text] [Related]
19. Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection.
Greenwood EJD; Williamson JC; Sienkiewicz A; Naamati A; Matheson NJ; Lehner PJ
Cell Rep; 2019 Apr; 27(5):1579-1596.e7. PubMed ID: 31042482
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.
de Silva S; Planelles V; Wu L
PLoS One; 2012; 7(5):e35385. PubMed ID: 22570689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
